scholarly article | Q13442814 |
P50 | author | Joshua J Rychak | Q106703594 |
Alexander Klibanov | Q4719325 | ||
P2860 | cites work | Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. | Q50757062 |
Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents. | Q50759455 | ||
Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. | Q51242178 | ||
Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice--initial results. | Q51819851 | ||
Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. | Q52545456 | ||
Ectopic transgenic expression of NKX2.2 induces differentiation of adult pancreatic progenitors and mediates islet regeneration. | Q53178712 | ||
Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. | Q53278662 | ||
Pharmacokinetics of plasmid DNA in the rat. | Q53893086 | ||
Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration | Q61667839 | ||
Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction | Q64377523 | ||
Development of inherently echogenic liposomes as an ultrasonic contrast agent | Q71352201 | ||
Ultrasound-mediated transfection of mammalian cells | Q71562001 | ||
Development of echogenic, plasmid-incorporated, tissue-targeted cationic liposomes that can be used for directed gene delivery | Q73504438 | ||
Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound | Q82692645 | ||
pDNA-loaded Bubble liposomes as potential ultrasound imaging and gene delivery agents | Q85942546 | ||
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure | Q24634002 | ||
Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles | Q30312032 | ||
Optimization of Ultrasound-mediated Anti-angiogenic Cancer Gene Therapy. | Q30385729 | ||
Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease | Q30414837 | ||
Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles | Q30416117 | ||
Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles | Q30417239 | ||
Gene therapy of carcinoma using ultrasound-targeted microbubble destruction | Q30434291 | ||
Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. | Q30446500 | ||
Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. | Q30447306 | ||
Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound | Q30447740 | ||
Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes. | Q30449753 | ||
Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer | Q30450076 | ||
Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery | Q30450567 | ||
Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons. | Q30455782 | ||
Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging | Q30458493 | ||
Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency | Q30460006 | ||
Encapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered release | Q30475079 | ||
Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis | Q30478078 | ||
Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology | Q30502097 | ||
Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading | Q30502398 | ||
Sonoporation of the minicircle-VEGF(165) for wound healing of diabetic mice | Q30853757 | ||
Targeted vascular delivery of antisense molecules using intravenous microbubbles | Q33235323 | ||
Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach | Q33730689 | ||
Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure. | Q33954952 | ||
Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy. | Q34101722 | ||
Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery | Q34476907 | ||
Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery | Q34564681 | ||
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity | Q35008409 | ||
Transient overexpression of cyclin D2/CDK4/GLP1 genes induces proliferation and differentiation of adult pancreatic progenitors and mediates islet regeneration | Q35866737 | ||
Polyelectrolyte multilayer capsules as vehicles with tunable permeability | Q35967498 | ||
Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles | Q36158355 | ||
Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology | Q37032987 | ||
Liposomal nanomedicines | Q37039021 | ||
In vivo gene delivery by nonviral vectors: overcoming hurdles? | Q38004708 | ||
Gene therapy clinical trials worldwide to 2012 - an update. | Q38077166 | ||
Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles | Q39107059 | ||
Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound | Q39170356 | ||
Microbubble attenuation and destruction: are they involved in sonoporation efficiency? | Q39216710 | ||
Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors | Q39441097 | ||
Ultrasound-mediated interferon β gene transfection inhibits growth of malignant melanoma | Q39514271 | ||
Ultrasound-mediated intracellular drug delivery using microbubbles and temperature-sensitive liposomes | Q39521329 | ||
Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. | Q39583871 | ||
Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy | Q39676282 | ||
Evaluation of the temporal window for drug delivery following ultrasound-mediated membrane permeability enhancement | Q39697051 | ||
Efficient, glucose responsive and islet-specific transgene expression by a modified rat insulin promoter | Q39804241 | ||
Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer | Q39842450 | ||
Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound | Q39937841 | ||
Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles. | Q40018333 | ||
Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth | Q40093861 | ||
Local delivery system of cytotoxic agents to tumors by focused sonoporation. | Q40175710 | ||
Artificial cavitation nuclei significantly enhance acoustically induced cell transfection | Q41028344 | ||
Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target | Q41179976 | ||
On bubbles and liposomes (June 11, 2007). | Q42459343 | ||
Ultrasound enhances gene expression of liposomal transfection | Q42833889 | ||
Effective in vitro and in vivo gene delivery by the combination of liposomal bubbles (bubble liposomes) and ultrasound exposure | Q43194931 | ||
mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells | Q43466253 | ||
Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents | Q43972381 | ||
Efficient gene delivery to myocardium with ultrasound targeted microbubble destruction and polyethylenimine | Q44098018 | ||
Ultrasonic gene and drug delivery using eLiposomes | Q44232707 | ||
Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities | Q44748382 | ||
Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction | Q45052109 | ||
Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. | Q45855475 | ||
Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques | Q45856251 | ||
Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage | Q45858769 | ||
Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. | Q45861934 | ||
Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model | Q45862411 | ||
Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart | Q45864640 | ||
Targeted retroviral gene delivery using ultrasound | Q45866153 | ||
Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1. | Q45867574 | ||
DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles | Q45869863 | ||
Which US Microbubble Contrast Agent Is Best for Gene Therapy? | Q45869882 | ||
Ultrasound and microbubble-assisted gene delivery in Achilles tendons: long lasting gene expression and restoration of fibromodulin KO phenotype. | Q45872956 | ||
Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration | Q45872998 | ||
Microbubble-enhanced ultrasound for vascular gene delivery | Q45874305 | ||
Sustained improvement in perfusion and flow reserve after temporally separated delivery of vascular endothelial growth factor and angiopoietin-1 plasmid deoxyribonucleic acid | Q45878241 | ||
Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats | Q45878832 | ||
Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. | Q45880567 | ||
Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles | Q45882823 | ||
Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents | Q45883538 | ||
Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. | Q45885266 | ||
Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models | Q45885389 | ||
Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice | Q45886981 | ||
Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection | Q45889188 | ||
Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation | Q46147948 | ||
Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in Doxorubicin-induced cardiomyopathy | Q46658317 | ||
Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. | Q46978141 | ||
Ultrasound-induced cell membrane porosity | Q47664572 | ||
Mechanism of intracellular delivery by acoustic cavitation | Q50249722 | ||
Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability | Q50452884 | ||
Intravascular ultrasound detection and delivery of molecularly targeted microbubbles for gene delivery. | Q50493096 | ||
Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. | Q50675944 | ||
Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo. | Q50679500 | ||
P4510 | describes a project that uses | microbubble | Q6839290 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | plasmid | Q172778 |
transfection | Q1429031 | ||
gene delivery | Q2790163 | ||
microbubble | Q6839290 | ||
focused ultrasound | Q50333304 | ||
P304 | page(s) | 82-93 | |
P577 | publication date | 2014-01-31 | |
P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
P1476 | title | Nucleic acid delivery with microbubbles and ultrasound. | |
P478 | volume | 72 |
Q46244037 | Advances in Stimulus-Responsive Polymeric Materials for Systemic Delivery of Nucleic Acids |
Q42146754 | Chondroitin sulfate-polyethylenimine copolymer-coated superparamagnetic iron oxide nanoparticles as an efficient magneto-gene carrier for microRNA-encoding plasmid DNA delivery |
Q38612534 | Design of Microbubbles for Gene/Drug Delivery |
Q92077815 | Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles |
Q30659317 | Evaluation of microbubble contrast agents for dynamic imaging with x-ray phase contrast |
Q49212853 | Homing of endogenous bone marrow mesenchymal stem cells to rat infarcted myocardium via ultrasound-mediated recombinant SDF-1α adenovirus in microbubbles |
Q47656366 | Increasing Distribution of Drugs Released from In Situ Forming PLGA Implants Using Therapeutic Ultrasound. |
Q38750014 | Influence of tumor cell lines derived from different tissue on sonoporation efficiency under ultrasound microbubble treatment |
Q51052987 | Intracellular triggered release of DNA-quaternary ammonium polyplex by ultrasound. |
Q36369503 | Laser-Activated Polymeric Microcapsules for Ultrasound Imaging and Therapy: In Vitro Feasibility |
Q90210921 | MRI Monitoring and Quantification of Ultrasound-Mediated Delivery of Liposomes Dually Labeled with Gadolinium and Fluorophore through the Blood-Brain Barrier |
Q39043064 | Materials Chemistry of Nanoultrasonic Biomedicine |
Q38794346 | Mechanoresponsive materials for drug delivery: Harnessing forces for controlled release |
Q30354561 | Microbubbles and ultrasound increase intraventricular polyplex gene transfer to the brain. |
Q36065021 | Microwave ablation-assisted liver gene transfection in rats |
Q38300052 | Minicircle DNA vectors for gene therapy: advances and applications. |
Q43376027 | Molecular Imaging of Cancer with Nanoparticle-Based Theranostic Probes |
Q30385033 | Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study. |
Q38697378 | Nanobubbles: a promising efficient tool for therapeutic delivery |
Q30385124 | Nanodroplet-Vaporization-Assisted Sonoporation for Highly Effective Delivery of Photothermal Treatment. |
Q59516605 | Nanoparticle-assisted ultrasound: A special focus on sonodynamic therapy against cancer |
Q28068242 | Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous System |
Q38586079 | Nucleic acid vaccination strategies against infectious diseases. |
Q52647655 | Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled In Situ Accumulation. |
Q52726026 | Pre-Treatment with Either L-Carnitine or Piracetam Increases Ultrasound-Mediated Gene Transfection by Reducing Sonoporation-Associated Apoptosis. |
Q30406257 | Sonochemotherapy: from bench to bedside |
Q50060960 | Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications |
Q47637792 | Strategies in the design of gold nanoparticles for intracellular targeting: opportunities and challenges |
Q47108344 | Theranostic Multilayer Capsules for Ultrasound Imaging and Guided Drug Delivery. |
Q53226839 | Theranostic agents: From micro to nano in seconds. |
Q94662961 | Therapeutic ultrasound experiments in vitro: Review of factors influencing outcomes and reproducibility |
Q91131848 | Transvascular Delivery of Hydrophobically Modified siRNAs: Gene Silencing in the Rat Brain upon Disruption of the Blood-Brain Barrier |
Q30359662 | Tumor growth suppression by the combination of nanobubbles and ultrasound. |
Q90804583 | Ultrasound with Microbubble Contrast Agent and Urokinase for Thrombosis |
Search more.